Hutch News
Results per Page:
HIV vaccine trials are complicated by the availability of PrEP
World AIDS Day 2020: Vaccine researchers still find ways to run trials amid growing use of HIV-prevention drugs
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of November 29, 2020
All immunogens are not created equal
From the Stamatatos lab, Vaccine and Infectious Disease Division
Benefits outweigh the social stigma of HIV vaccine trial participation
From the HIV Vaccine Trials Network and the University of Washington
After 20 years, Wakefield retires from HIV Vaccine Trials Network
'He created the DNA of our organization'
Immune surveillance triggers HIV reactivation
From the Hladik lab, Vaccine and Infectious Disease Division
Fine-tuning B cell responses
From the Taylor Lab, Vaccine and Infectious Disease Division
Promising HIV vaccine fails to show efficacy, trial halted
Based on earlier vaccine that was partly effective, researchers tried modified version
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
HIV vaccine trial uncovers plausible mechanisms of protection
From the HVTN, Vaccine and Infectious Disease Division
Baiting for B cells: A clever new way to make an AIDS vaccine
Researchers fish for rare blood cells that can evolve into HIV blockers
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
Increased racial and ethnic minority participation in HIV vaccine trials
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Fred Hutch’s Dr. Adam Dingens a 2019 Weintraub Award recipient
He is among 13 graduate students selected for this prestigious award in biological sciences
Scientists strategize to stop HIV infections, work toward cure
A hot topic for a big scientific conference convening in Seattle
Cutting-edge approach maps HIV's escape routes
Atlas of immune-evading HIV mutations could inform design of new treatments, vaccines
Modified HIV immunogens engage neutralizing antibody precursors
From the Stamatatos lab, Vaccine and Infectious Disease Division
'Cautiously optimistic about HIV vaccines'
A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
Wild-type vs. modification: which is better?
From Stamatatos Laboratory, Vaccine and Infectious Disease Division